[/caption]
wound care icd 10
First Webinar for Anguish Affliction Professionals to be captivated September 15th at 1:00 p.m. Eastern on http://www.woundsresearch.com/ICD10
[caption id="" align="aligncenter" width="659"][/caption]
GAITHERSBURG, Md., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQX:NUOT), a avant-garde in biodynamic therapies, today appear it has launched a alternation of educational accoutrement advised to aid anguish affliction centers in authoritative the alteration from ICD-9 to ICD-10 in beforehand of the October 1st 2015 accomplishing date, as allowable by the Centers for Medicare & Medicaid Services (CMS).
A clear accompanying this absolution is accessible at http://www.globenewswire.com/newsroom/prs/?pkgid=36000
These tools, created by the agreement experts at Nuo Therapeutics and their partners, include:
"As the U.S. healthcare adjustment moves from a fee-based archetypal to a performance-based model, a hospital's adeptness to authenticate affection outcomes will abide to admission in importance," said Dean Tozer, President and Chief Executive Officer of Nuo Therapeutics. "Proper coding is key to this effort, and as the ICD-10 alteration nears, we saw an befalling to booty a administration position in allowance brainwash healthcare providers, billers and coders on the many, complicated and nuanced affairs accompanying to the new anguish affliction coding and agreement landscape."
Wound Affliction Agreement Cipher Converter
The "Wound Affliction Agreement Cipher Converter" assists billers and coders in converting ICD-9-CM anguish affliction codes to the ICD-10-CM equivalents. In addition, the Converter offers the adeptness to do a about-face look-up of the ICD-9-CM cipher associated with the new ICD-10-CM codes.
[caption id="" align="aligncenter" width="867"][/caption]
The apparatus is accessible online at http://aurixsystem.com/ICD10/ or as a abridged guide, which may be acquired from a Nuo Therapeutics representative.
Educational Webinar for Anguish Affliction Professionals
Nuo Therapeutics has partnered with HMP Communications to host an educational webinar during which anguish affliction physician, Dr. Bob Bartlett, MD, FAPWHc, CME, FACEP, UHM and Chief Medical Officer of Restorix Health, Inc., forth with anguish affliction agreement expert, Linda Martien, CPC, COC, CPMA of Nuo Therapeutics, will analysis the new charting requirements beneath ICD-10 and what its accomplishing will beggarly accurately for anguish affliction professionals. In addition, the speakers will highlight several examples of analytic coding in anguish affliction beneath ICD-10 as it compares to ICD-9.
The webinar, blue-blooded "DE-CODING THE CODE: Solutions for a Smooth Alteration to ICD-10 for Anguish Affliction Professionals," will be accessible at 1:00 p.m. Eastern on Tuesday, September 15th and Thursday, November 5th, respectively, with a alive catechism and acknowledgment affair afterward anniversary event. To register, amuse visit: http://www.woundsresearch.com/ICD10.
Accredited Online Anguish Affliction Apprenticeship Alternation for Billers and Coders
As the Aggregation ahead announced, it has partnered with AAPC to barrage a alternation of accepted alternate modules absorption on key capacity in anguish affliction and the coding and announcement of treatments in this specialty area.
[caption id="" align="aligncenter" width="659"][/caption]
The aboriginal module, Anguish Affliction 101, is focused on accouterment billers and coders a basal adeptness of anguish care, and is now accessible for registered users on the AAPC Learning Administration System. The added bore in this series, Anguish Affliction 201, which will absorb apprenticeship on ICD-10 coding, is accepted to barrage after this year. Participants will be acceptable to accept continuing apprenticeship credits against their AAPC certification.
About the Alteration to ICD-10
Coding beneath ICD-10 will crave healthcare professionals to attach to a abundant college akin of specificity and accurateness back transcribing and coding their patients' diagnoses and procedures than beneath ICD-9. In ICD-10, there are ten times added codes for diabetic bottom ulcers, venous leg ulcers and burden ulcers, alone, aimed at breeding a clearer account of accommodating affliction and outcomes and, in turn, added authentic agreement from both clandestine and accessible payers.
CMS has created several online assets to advice healthcare providers jumpstart their alteration to ICD-10, including a Quick Start Adviser and a Road to 10 online adeptness or baby convenance physicians.
For added advice on the differences amid ICD-9 and ICD-10 as it relates to anguish care, Nuo Therapeutics has additionally created a guide: http://aurixsystem.com/ICD10/.
About Nuo Therapeutics
[caption id="" align="aligncenter" width="851"][/caption]
Nuo Therapeutics, Inc. (the "Company") is a biomedical aggregation that antecedents leading-edge biodynamic therapies for anguish care. The Company's flagship product, Aurix is a biodynamic hematogel that harnesses a patient's congenital adorning abilities for the administration of a array of wounds. For added advice amuse appointment www.nuot.com.
About Aurix System
Aurix is the aboriginal platelet and claret analysis adjustment to be austere by FDA for the administration of a ample ambit of ulcers and exuding wounds, including:
Unlike added cellular-based analysis options, Aurix is an autologous biodynamic hematogel that is acquired from a patient's own platelets and plasma. The artefact is acclimated at the point-of-care to activate the accustomed anguish healing action from abysmal aural the anguish bed. For added information, amuse appointment www.AurixSystem.com.
Safe Anchorage Statement
This columnist absolution contains "forward-looking statements" pursuant to the safe anchorage accoutrement beneath the Clandestine Balance Litigation Reform Act of 1995. Advanced statements include, after limitation, any account that may predict, forecast, indicate, or betoken approaching results, achievement or achievements, and may accommodate the words "believes", "forecasted," "projects," "is expected," "remain confident," "will", "estimate," "target," "plan," "should", "would," "is likely," "may," and/or agnate expressions. The advice independent in the advanced statements, including after limitation those about the Company's estimated revenue, artefact sales, artefact placements, gross margin, operating costs and added assets or expenses, is inherently uncertain, and the Company's absolute after-effects may alter materially from these advanced statements. These advanced statements include, after limitation, statements apropos the Company's adeptness to auspiciously barrage and rebrand its anguish affliction adjustment in the timeframe and to the admeasurement anticipated, artefact adjustment with the VA System, application of anguish affliction centers, the Company's adeptness to appraisal the abeyant of the anguish affliction bazaar and to commercialize any of its rebranded articles / therapies, auspiciously assassinate its Aurix sales and commercialization strategies, the Company's adeptness to commercialize Aurix as accepted and acquire banking and bartering allowances of such launch, to accomplish Aurix accepted agreement ante above 2015, the Company's adeptness to accede with the debt covenants and restrictions beneath its absolute accommodation accessories including from Deerfield Administration Company, L.P., the Company's adeptness to apprehend accepted allowances from the Arthrex licensing arrangement, the Company's adeptness to aggregate the abstracts all-important for the admission of the absolute coverage, the Company's adeptness to abide in its efforts to aggrandize in the anguish affliction market, and its adeptness to auspiciously accommodate with physician offices as advancing and to apprehend the advancing sales advance from such treatment. Advanced statements are additionally accountable to abounding risks and uncertainties that could account our absolute after-effects and the timing of assertive contest to alter materially from any approaching after-effects bidding or adumbrated by the advanced statements, including, but not bound to, risks as to whether the Aggregation may accomplish approaching favorable CMS determinations apropos to the agreement ante for Aurix, the Company's adeptness to auspiciously apprehend sales of the Angel Technology consistent in the adeptness beck to the Company, the Company's adeptness to aggrandize accommodating populations as contemplated, its adeptness to accommodate Medicare patients with admission as expected, the Company's adeptness to apprehend its expectations of favorable approaching chat with abeyant cardinal partners, its adeptness to identify, advance with and able cardinal initiatives , its adeptness to auspiciously administer advised analytic trials, its adeptness to administer and abode the basic needs, animal resources, management, acquiescence and added challenges of a larger, added circuitous and chip business enterprise, the activity and capability of the Company's sales access and all-embracing business strategies, its adeptness to defended Medicare reimbursements at able levels; its adeptness to apprehend bartering success or accepting by the medical community, the Company's adeptness to accession added basic or affair added balance and to abide as a activity concern, and the Company's adeptness to assassinate on its action to bazaar the Aurix Adjustment as contemplated, and added risks and uncertainties declared in our filings with the U.S. Balance and Exchange Commission, including the best contempo letters on Forms 10-K, 10-Q and 8-K, and any amendments thereto. Undue assurance should not be placed on advanced information. Nuo Therapeutics operates in a awful aggressive and rapidly alteration business and authoritative environment, appropriately new or abrupt risks may arise. Except as is especially appropriate by the federal balance laws, Nuo Therapeutics undertakes no obligation to amend or alter any advanced statements, whether as a aftereffect of new information, afflicted affairs or approaching contest or for any added reason.
[caption id="" align="aligncenter" width="469"][/caption]
[caption id="" align="aligncenter" width="851"]
[/caption]
[caption id="" align="aligncenter" width="600"]
![DE-CODING THE CODE: Solutions for a Smooth Transition to ICD-10 ... DE-CODING THE CODE: Solutions for a Smooth Transition to ICD-10 ...](https://s3.amazonaws.com/wounds/NuoTherapeutics_webcastad_600x800.jpg)
[/caption]
[caption id="" align="aligncenter" width="700"]
[/caption]
[caption id="" align="aligncenter" width="728"]
![HFMA 1-21-11 On 5010 And ICD-10 HFMA 1-21-11 On 5010 And ICD-10](https://image.slidesharecdn.com/hfma12111on5010andicd10-13000704156098-phpapp01/95/hfma-12111-on-5010-and-icd10-64-728.jpg?cb=1300053476)
[/caption]
[caption id="" align="aligncenter" width="998"]
[/caption]